System Chief, Cancer Massachusetts General Hospital

Shelby Memorial Professor of Medicine in the Field of Cancer Therapeutics Harvard Medical School

Physician Medicine-Hematology/Oncology, Massachusetts General Hospital

MD Columbia University College of Physicians & Surgeons 1992

adenocarcinoma; antineoplastic combined chemotherapy protocols; anus neoplasms; colorectal neoplasms; deoxycytidine; pancreatic cancer; pancreatic neoplasms; peritoneal neoplasms; rectal neoplasms The principal focus of David’s clinical research is the design and implementation of Phases I and II trials in gastrointestinal malignancies. Since 1998 he has been a member of both the Experimental Therapeutics Group and the Gastrointestinal Cancer Center where he has been the Clinical Director since 2003. In 2009, he became the Clinical Director of the MGH Cancer Center and in 2012, became Chief of the MGH Cancer Center. David’s clinical practice focuses exclusively on gastrointestinal oncology.